Optiray Injection
NDC Package 0019-1333-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information
NDC HCPCS Crosswalk
Other Packages
Frequently Asked Questions

Package Information

Optiray (ioversol) injection is optiray is indicated for:. This formulation utilizes a injection delivery system. Marketed by Liebel-flarsheim Company Llc, this product is identified by NDC 0019-1333 and is authorized under FDA application NDA019710.

Identification & Billing

NDC Package Code

0019-1333-06

Package Description

25 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS

Product Code

0019-1333

11-Digit Billing Format

00019133306

Billing Unit

ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name

Optiray 350

Non-Proprietary Name

Ioversol

Substance Name

Ioversol

Dosage Form

Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.

Administration Route

Intra-arterial - Administration within an artery or arteries.
Intravenous - Administration within or into a vein or veins.
Intra-arterial - Administration within an artery or arteries.
Intravenous - Administration within or into a vein or veins.
Intra-arterial - Administration within an artery or arteries.
Intravenous - Administration within or into a vein or veins.

Active Ingredient(s)

Pharmacologic Class

Usage Information

Optiray is indicated for:

Regulatory & Marketing

Labeler Name

Liebel-flarsheim Company Llc

Product Type

Human Prescription Drug

FDA Application #

NDA019710

Marketing Category

NDA - A product marketed under an approved New Drug Application.

Start Marketing Date

03-04-2012

Listing Expiration

12-31-2026

Exclude Flag

Sample Package

Hierarchy Structure

Code Lineage

0019 - Liebel-flarsheim Company Llc
- 0019-1333 - Optiray
  - 0019-1333-06 - 25 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Q9967

Source: ASP

Locm 300-399mg/ml iodine,1ml

HCPCS Dosage 1 ML

Units / Pkg 1250

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0019-1333). Click a package code to view its specific billing and regulatory data.

0019-1333-00

20 SYRINGE, PLASTIC in 1 CARTON / 100 mL in 1 SYRINGE, PLASTIC

0019-1333-11

12 BOTTLE, GLASS in 1 CARTON / 100 mL in 1 BOTTLE, GLASS

0019-1333-16

12 BOTTLE, GLASS in 1 CARTON / 150 mL in 1 BOTTLE, GLASS

0019-1333-21

12 BOTTLE, GLASS in 1 CARTON / 200 mL in 1 BOTTLE, GLASS

0019-1333-27

20 SYRINGE, PLASTIC in 1 CARTON / 125 mL in 1 SYRINGE, PLASTIC

0019-1333-51

12 BOTTLE, GLASS in 1 CARTON / 250 mL in 1 BOTTLE, GLASS

0019-1333-52